378 related articles for article (PubMed ID: 30707946)
21. Bioinformatics analysis of immune characteristics in tumors with alternative carcinogenesis pathways induced by human papillomaviruses.
Smahel M; Nunvar J
Virol J; 2023 Dec; 20(1):287. PubMed ID: 38049810
[TBL] [Abstract][Full Text] [Related]
22. Human Papillomaviruses as Infectious Agents in Gynecological Cancers. Oncogenic Properties of Viral Proteins.
Haręża DA; Wilczyński JR; Paradowska E
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163748
[TBL] [Abstract][Full Text] [Related]
23. Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus.
Braakhuis BJ; Snijders PJ; Keune WJ; Meijer CJ; Ruijter-Schippers HJ; Leemans CR; Brakenhoff RH
J Natl Cancer Inst; 2004 Jul; 96(13):998-1006. PubMed ID: 15240783
[TBL] [Abstract][Full Text] [Related]
24. HPV: Molecular pathways and targets.
Gupta S; Kumar P; Das BC
Curr Probl Cancer; 2018; 42(2):161-174. PubMed ID: 29706467
[TBL] [Abstract][Full Text] [Related]
25. Molecular mechanisms underlying human papillomavirus E6 and E7 oncoprotein-induced cell transformation.
Mittal S; Banks L
Mutat Res Rev Mutat Res; 2017; 772():23-35. PubMed ID: 28528687
[TBL] [Abstract][Full Text] [Related]
26. Papillomavirus E5: the smallest oncoprotein with many functions.
Venuti A; Paolini F; Nasir L; Corteggio A; Roperto S; Campo MS; Borzacchiello G
Mol Cancer; 2011 Nov; 10():140. PubMed ID: 22078316
[TBL] [Abstract][Full Text] [Related]
27. Carcinogenesis Associated with Human Papillomavirus Infection. Mechanisms and Potential for Immunotherapy.
Vonsky M; Shabaeva M; Runov A; Lebedeva N; Chowdhury S; Palefsky JM; Isaguliants M
Biochemistry (Mosc); 2019 Jul; 84(7):782-799. PubMed ID: 31509729
[TBL] [Abstract][Full Text] [Related]
28. The role of human papillomavirus oncoproteins E6 and E7 in apoptosis.
Finzer P; Aguilar-Lemarroy A; Rösl F
Cancer Lett; 2002 Dec; 188(1-2):15-24. PubMed ID: 12406543
[TBL] [Abstract][Full Text] [Related]
29. The effects of HPV oncoproteins on host communication networks: Therapeutic connotations.
Skelin J; Luk HY; Butorac D; Boon SS; Tomaić V
J Med Virol; 2023 Dec; 95(12):e29315. PubMed ID: 38115222
[TBL] [Abstract][Full Text] [Related]
30. HPV E6/E7: insights into their regulatory role and mechanism in signaling pathways in HPV-associated tumor.
Peng Q; Wang L; Zuo L; Gao S; Jiang X; Han Y; Lin J; Peng M; Wu N; Tang Y; Tian H; Zhou Y; Liao Q
Cancer Gene Ther; 2024 Jan; 31(1):9-17. PubMed ID: 38102462
[TBL] [Abstract][Full Text] [Related]
31. E5 and E6/E7 of high-risk HPVs cooperate to enhance cancer progression through EMT initiation.
Al Moustafa AE
Cell Adh Migr; 2015; 9(5):392-3. PubMed ID: 26177717
[TBL] [Abstract][Full Text] [Related]
32. Regulation of autophagy by high- and low-risk human papillomaviruses.
Aranda-Rivera AK; Cruz-Gregorio A; Briones-Herrera A; Pedraza-Chaverri J
Rev Med Virol; 2021 Mar; 31(2):e2169. PubMed ID: 33590566
[TBL] [Abstract][Full Text] [Related]
33. Interactions of HPV E6 and E7 oncoproteins with tumour suppressor gene products.
Münger K; Scheffner M; Huibregtse JM; Howley PM
Cancer Surv; 1992; 12():197-217. PubMed ID: 1322242
[TBL] [Abstract][Full Text] [Related]
34. The E5 gene of HPV-16 enhances keratinocyte immortalization by full-length DNA.
Stöppler MC; Straight SW; Tsao G; Schlegel R; McCance DJ
Virology; 1996 Sep; 223(1):251-4. PubMed ID: 8806560
[TBL] [Abstract][Full Text] [Related]
35. Human papillomavirus type 16 E5 oncoprotein as a new target for cervical cancer treatment.
Kim MK; Kim HS; Kim SH; Oh JM; Han JY; Lim JM; Juhnn YS; Song YS
Biochem Pharmacol; 2010 Dec; 80(12):1930-5. PubMed ID: 20643111
[TBL] [Abstract][Full Text] [Related]
36. Human papillomavirus type 16 E5 protein as a therapeutic target.
Kim SW; Yang JS
Yonsei Med J; 2006 Feb; 47(1):1-14. PubMed ID: 16502480
[TBL] [Abstract][Full Text] [Related]
37. [Virological and carcinogenic aspects of HPV].
Prétet JL; Charlot JF; Mougin C
Bull Acad Natl Med; 2007 Mar; 191(3):611-23; discussion 623. PubMed ID: 18072657
[TBL] [Abstract][Full Text] [Related]
38. Modulation of apoptosis by early human papillomavirus proteins in cervical cancer.
Lagunas-Martínez A; Madrid-Marina V; Gariglio P
Biochim Biophys Acta; 2010 Jan; 1805(1):6-16. PubMed ID: 19374936
[TBL] [Abstract][Full Text] [Related]
39. Novel effect of the high risk-HPV E7 CKII phospho-acceptor site on polarity protein expression.
Dizanzo MP; Bugnon Valdano M; Basukala O; Banks L; Gardiol D
BMC Cancer; 2022 Sep; 22(1):1015. PubMed ID: 36153517
[TBL] [Abstract][Full Text] [Related]
40. Development of an adenoviral vaccine against E6 and E7 oncoproteins to prevent growth of human papillomavirus-positive cancer.
Lee DW; Anderson ME; Wu S; Lee JH
Arch Otolaryngol Head Neck Surg; 2008 Dec; 134(12):1316-23. PubMed ID: 19075129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
